The Valley Desk

ArticleJournal of the advanced practitioner in oncologyPublished

Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Article
Venue
Journal of the advanced practitioner in oncology
Published
PubMed ID
37009408
PubMed Central ID
PMC10062534
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal